Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss For The Period	$ (619,943)	$ (556,568)	$ (3,460,408)	$ (1,379,055)	$ (2,337,338)
Adjustments to Reconcile Net Loss to Net Cash (Used in) Provided by Operating Activities:
Return of escrowed shares to Treasury			(177,600)
Inducement Dividend from Warrant Exercise				30,000
Gain on Settlement of Debt		(22,000)		(22,000)
Common stock issued by Officer on behalf of PetVivo			77,354
Stock issued for services			611,951
Stock to be issued for production services			56,333
Stock Based Compensation			861,592	321,523
Stock Compensation Adjustment				(342,727)
Amortization of Debt Discount on Notes Payable to Interest Expense			60,305
Interest accrued on Notes Payable			8,776
Beneficial Conversion Feature			66,248
Warrants granted in conjunction with bridge notes less debt discount effect			14,181
Warrants for services			99,132
Warrant compensation - Advisors			197,925
Warrant compensation - Directors			152,873
Warrant compensation - Employees			161,750
Warrant compensation - Officers			102,863
Depreciation and amortization			485,331	483,317
Changes in Operating Assets and Liabilities
Increase in inventory			(22,608)
Increase in prepaid expense and employee advances			(10,090)	(13,833)
Decrease (increase) in advances and receivables			163	(1,000)
Decrease in accrued expense - related parties			(98,108)
Increase in accounts payable and accrued expense			209,685	677,924
Net Cash Used In Operating Activities			(602,352)	(245,851)
CASH FLOWS FROM INVESTING ACTIVITIES
Decrease (increase) in security deposit			1,999	(8,201)
Purchase of equipment			(23,181)	(8,768)
Increase in patents and trademarks			(70,040)	(19,643)
Net Cash Used in Investing Activities			(91,222)	(36,612)
CASH FLOWS FROM FINANCING ACTIVITIES
Stock issued for cash - warrant exercises			189,549
Stock issued for cash - discounted warrant exercise agreements			200,456
Stock issued for cash				877,000
Proceeds from Notes Payable			215,000
Proceeds from Notes Payable - related parties			50,000
Repayments of Notes Payable - related parties			(12,085)	(2,168)
Repayments of loans and line of credit				(60,902)
Net Cash Provided by Financing Activities			642,920	813,930
Net Increase (decrease) in Cash			(50,654)	531,467
Cash at Beginning of Period			237,335	25,434	25,434
Cash at End of Period	$ 186,681	$ 556,901	186,681	556,901	$ 237,335
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash Paid During The Year For: Interest			13,879
Cash Paid During The Year For: Income taxes paid
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Shares issued as payment for accrued salaries				1,209,919
Change in variable interest equity				14,335,730
Notes Payable converted into common stock			(150,000)	(12,500)
Notes Payable converted into common stock - related parties			(70,000)
Notes Payable interest converted into common stock			(4,280)
Notes Payable interest converted into common stock - related parties			(1,722)
Increase in Debt Discount on Notes Payable			(65,557)
Shares issued to reduce debt			$ 387,713	$ 13,210